HLN.L
Price:
$372.2
Market Cap:
$33.92B
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2022-07-18
Stock Exchange
LSE
Ticker
HLN.L
According to Haleon plc’s latest financial reports and current stock price. The company's current Current Ratio is 0.84. This represents a change of 78.58% compared to the average of 0.47 of the last 4 quarters.
The mean historical Current Ratio of Haleon plc over the last ten years is 1.16. The current 0.84 Current Ratio has changed 7.10% with respect to the historical average. Over the past ten years (40 quarters), HLN.L's Current Ratio was at its highest in in the June 2022 quarter at 3.43. The Current Ratio was at its lowest in in the March 2021 quarter at 0.
Average
1.16
Median
1.24
Minimum
0.93
Maximum
1.36
Discovering the peaks and valleys of Haleon plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 11.79%
Maximum Annual Current Ratio = 1.36
Minimum Annual Increase = -25.04%
Minimum Annual Current Ratio = 0.93
Year | Current Ratio | Change |
---|---|---|
2023 | 1.04 | 11.79% |
2022 | 0.93 | -25.04% |
2021 | 1.24 | -0.69% |
2020 | 1.25 | -8.34% |
The current Current Ratio of Haleon plc (HLN.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.07
5-year avg
1.16
10-year avg
1.16
Haleon plc’s Current Ratio is greater than GSK plc (0.81), greater than Reckitt Benckiser Group plc (0.69), greater than M&G plc (0.77), less than abrdn plc (225.80), greater than Legal & General Group Plc (0.48),
Company | Current Ratio | Market cap |
---|---|---|
0.81 | $57.90B | |
0.69 | $34.47B | |
0.77 | $4.61B | |
225.80 | $2.36B | |
0.48 | $12.87B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Haleon plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Haleon plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Haleon plc's Current Ratio?
How is the Current Ratio calculated for Haleon plc (HLN.L)?
What is the highest Current Ratio for Haleon plc (HLN.L)?
What is the 3-year average Current Ratio for Haleon plc (HLN.L)?
What is the 5-year average Current Ratio for Haleon plc (HLN.L)?
How does the current Current Ratio for Haleon plc (HLN.L) compare to its historical average?